Menu
Česky English
532 23 1111
Česky English
Areál Bohunice
Dětská nemocnice
Porodnice
Úvodní stránka

Články v zahraničních časopisech - 2006

Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V, Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Letters 239, 2006, 46-54  IF 3,049

  1. Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V, Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Letters 239, 2006, 46-54  IF 3,049
  2. Doubek M., Koristek Z., Havranova D., Smardova L., Mayer J.: Megakaryocyte colony-forming unit growth is enhanced by alemtuzumab: in vitro experiments and a case report of acquired amegakaryocytic thrombocytopenic purpura. Leukemia, 20, 2006, 1618-1649  IF 6,612
  3. Dvorak P., Dvorakova D., Hampl A.: Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Letters, 580, 2006, 2869-2874  IF 3,415
  4. Elbl L, Hrstkova H, Tomaskova I, Michalek J. Late anthracycline cardiotoxicity protection by dexrazoxane (ICRF-187) in pediatric patients: Echocardiographic follow-up. Support Care Cancer 2006;2(14):128-136  IF=1,59
  5. Elbl L, Kral Z, Tomaskova I, Smardova L, Wagnerova B, Jedlicka F, Vasova I, Vorlicek J. The evaluation of acute and early cardiotoxicity in survivors of Hodgkin’s disease treated by ABVD or BEACOPP regimens. J Chemotherapy 2006;4(18):20-29  IF 1,147
  6. Elbl L, Vasova I, Kral Z, Navratil M, Smardova L, Vorlicek J. Evaluation of early and chronic cardiotoxicity adult patients treated for Hodgkin´s disease with ABVD regimen. Neoplasma 2006;53(1):586-590  IF 0,731
  7. Elbl L, Vasova I, Tomaskova I, Jedlicka F, Kral Z, Navratil M, Smardova L, Wagnerova B, Vorlicek J. Cardiopulmonary exercise tests in the evaluation of functional capacity after treatment of lymphomas in adults. Leukemia&Lymphoma 2006;47:1-9  IF 1,295
  8. Elbl L, Vasova I, Tomaskova I, Jedlicka F, Navratil M, Vorlicek J. Cardiac abnormalities and cardiopulmonary performance in patients with non-Hodgkin’s lymphoma treated by CHOP regimen. Neoplasma 2006;53(2):174-181   IF 0,731
  9. Hermanova M., Zapletalova E., Sedláčkova J., Chrobakova T., Letocha O., Kroupova I., Zamecnik J., Vondráček P., Mazanec R., Marikova T., Vohanka S. and Fajkusova L.: Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patiens. Muscle Nerve 2006 Mar;33(3):424-32.  IF 1,898
  10. Horky D., Lauschova I., Klabusay M., Doubek M., Sheer P., Palsa S., Doubek J.: Appearance of iron-labeled blood mononuclear cells in elektron mikroskopy. Veterinarni Medicina, 51, 2006 (3): 89-92  IF 0,76
  11. Huser M., Jurankova E., Crha I., Ventruba P., Hudecek R., Zakova J., Smardova L., Kral Z.: Fertility preservation strategies in women undergoing chemotherapy for heamatological malignancy. Eur Clinics Obstet Gynaecol 2006, 2: 77-81  IF 0,776
  12. Jahn P., Doubek J., Doubek M., Bouda M.: Idiopathic thrombocytopenic purpura and anaemia in a pregnant mare. Equine veterinary education, 18, 2006 (2): 80-83  IF 0,38
  13. Kaminek M., Meluzin J., Janousek S., Groch L., Panovsky R., Klabusay M., Mayer J., Prasek J., Stanicek J., Rehak Z., Myslivecek M.: The role of quantitative Tc-99m-MIBI gated SPECT/F-18-FDG PET imaging in the monitoring of intracoronary bone marrow cell transplantation. Nucl Med Rev Cent East Eur, 9(1), 2006; 60-64.
  14. Kaminek M., Meluzin J., Janousek S., Pacovsky R., Mayer J., Klabusay M., et al.: Reparai of infarcted myocardium by bone marrow cell transplantation: Individual differences in the effectiveness of therapy assessed by MIBI SPECT/FGD PET imaging. Eur Nucl Med 33, 2006, Suppl. 2: S 152  IF 3,935
  15. Klabusay M., Kohutova V., Coupek P., Nenickova M., Tesarova E.: Simultaneous analysis of cytokines and co-stimulatory molecules concentrations by ELISA technique and of probabilities of measurable concentrations of interleukins IL-2, IL-4., IL-5, IL-6, CXCL8 (IL-8), IL-10, IL-13 occuring in plasma of healthy blood donors. Mediators of Inflammation, 2006 (2006). IF- 0,953.
  16. Koutna I., Klabusay M., Kohutova V., Krontorad P., Svoboda Z., Kozubek M., Mayer J: Evaluation od CD34+ and Lin- selected cells from peripheral blood stem cell grafts of patients with lymphoma during differentiation in culture ex vivo using a cDNA microarray technique. Exp. Hematol. 34, 2006, 832-840  IF 4,019
  17. Kozák L., Hrabincová E., Kintr J., Horký O., Zapletalová P., Blaháková I., Mejstřík P., Procházková D.: Identification and characterization of large deletions in the phenylalanine hydroxylase (PAH) gene by MLPA: Evidence for both homologous and non-homologous mechanisms of rearrangement. Molecular Genetics and Metabolism 89, 2006, 300-309  IF 1,235
  18. Krejci M., Mayer J., Doubek M., Brychtova Y., Pospisil Z., Racil Z., Dvorakova D., Lengerova M., Horky o., Koristek Z., Dolezal T., Vorlicek J.: Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia. Bone Marrow Transplantation, 38, 2006, 483-491  IF 2,643
  19. Meluzín J., Mayer J., Groch L., Janoušek S., Horňáček I., Hlinomaz O., Kala P., Panovský R., Prášek J., Kamínek M., Staníček J., Klabusay M., Kořístek Z., Navrátil Z., Dušek L., Vinklárková J.: Autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction: The effect of the dose of transplanted cells on myocardial function. Am Heart J. 152, 2006, 5: 975.e10-975.e15  IF 3,552
  20. Schwarz J., Pytlik R., Doubek M., Brychtova Y., Dulicek P., Campr V., Kren L., Penka M.: Analysis of risk factors: The rationale of the guidelines of the Czech Hematological Society for diagnosis and treament of chronic myeloproliferative disorders with trombocythemia. Semin. Thromb. Hemost. 32, 2006, 3: 231-245  IF 2,027
  21. Trbusek M., Malcikova J., Smardova J., Kuhrova V., Mentzlova D., Francova H., Bukovska S., Svitakova M., Kuglik P., Linkova V., Doubek M., Brychtova Y., Zacal J., Kujickova J., Pospíšilova S., Dvořákova D., Vorlicek J., Mayer J.: Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. Leukemia, 20, 2006, 1159-1161  IF 6,612
  22. Varga G., Volková Z., Leibl H., Gasztonyi Z., Hlusi A., Mayer J., Chojnowski K., Wolf H., Sharkhawy M., Pavlova B., et al.: Efficacy and safety of the new intravenous immunoglobulin IGIV 10% in adults with chronic idiopathic thrombocytopenic purpura. Transfus Med Hemother, 33, 2006: 509-514  IF 0,449
  23. Vyzula R., Kocakova I., Demlova R., Kiss I., Dusek L., Jarkovsky J.: Raltitredex plus oxaliplatin in the second-line treatment of metastatic colorectal cancer. Neoplasma, 53, 2006, 2: 119-127  IF 0,731

FN Brno je státní příspěvková organizace zřízená rozhodnutím Ministerstva zdravotnictví. Nemá zákonnou povinnost zápisu do obchodního rejstříku, je zapsána do živnostenského rejstříku vedeného Živnostenským úřadem města Brna.

Fakultní nemocnice Brno - snadné čtení (dle metodiky „Easy to read“) Srozumitelné informace

Bohunice Dětská nemocnice Porodnice

Jihlavská 20, Brno
Telefon: 532 23 1111
E-mail:

Nastavení soukromí

© Fakultní nemocnice Brno. Všechna práva vyhrazena. | developed by Via Aurea s.r.o.

Informace o pohotovosti v Brně a Jihomoravském kraji